{"id":379239,"date":"2020-11-12T03:18:53","date_gmt":"2020-11-12T08:18:53","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379239"},"modified":"2020-11-12T03:18:53","modified_gmt":"2020-11-12T08:18:53","slug":"neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/","title":{"rendered":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">STOCKHOLM<\/span>, <span class=\"xn-chron\">Nov. 12, 2020<\/span> \/PRNewswire\/ &#8212;<b>\u00a0NeoDynamics AB (publ), (Spotlight Stockholm: NEOD), today announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new potential indication, osteoarthritis.<\/b><\/p>\n<p>The William Hunter Revisited research consortium consists of six universities and academic hospitals and is collaborating with industry to identify biomarkers and test new diagnostic devices for monitoring disease progression and repair as well as developing regenerative therapies for osteoarthritis.<\/p>\n<p>&#8220;We look forward to collaborating with NeoDynamics and leveraging their expertise and technology to improve biopsy technique and tissue sampling in patients with osteoarthritis&#8221;, says Dr. <span class=\"xn-person\">Pieter Emans<\/span>, Orthopedic Surgeon at Maastricht UMC.<\/p>\n<p>&#8220;The collaboration with the consortium is a great opportunity for NeoDynamics, it gives us access to a network of leading clinicians and researchers in the field of osteoarthritis. Naturally we are interested to evaluate our technology platform beyond the breast cancer area&#8221;, says Kai-Uwe Sch\u00e4ssburger, Ph.D. Director Clinical Development &amp; Medical Affairs of NeoDynamics. &#8220;This will further validate our pulse biopsy system NeoNavia and explore the potential use in Osteoarthritis&#8221;.<\/p>\n<p>Osteoarthritis is the most common form of arthritis, affecting more than 100 million patients around the world. It occurs when the protective cartilage that cushions the end of the bones gradually deteriorates and is the 4th leading cause of mobility-associated disability. Osteoarthritis is a degenerative disease that worsens over time often resulting in chronic pain. Societal costs are immense and reaching 15 Billion per year in <span class=\"xn-location\">the Netherlands<\/span> alone. There is a significant need to developing innovative tools for tissue sampling, and analysis of disease progression to optimize individual treatment options. <\/p>\n<p>\n        <i>The information was submitted for publication through the agency of the contact person set out below, at <span class=\"xn-chron\">08:55 CET<\/span> on <span class=\"xn-chron\">November 12, 2020<\/span><\/i>\n      <\/p>\n<p>\n        <b>For additional information please contact:<\/b>\u00a0 <\/p>\n<p>\n        <span class=\"xn-person\">Anna Eriksrud<\/span>, CEO NeoDynamics AB (publ). Phone +46\u00a0708\u00a0444\u00a0966 e-mail: <a target=\"_blank\" href=\"mailto:anna.eriksrud@neodynamics.com\" rel=\"nofollow noopener noreferrer\">anna.eriksrud@neodynamics.com<\/a><\/p>\n<p>J\u00f6rgen Vrenning, CFO\/IR NeoDynamics AB (publ). Phone +46\u00a0708 519 648 e-mail:\u00a0<a target=\"_blank\" href=\"mailto:jorgen.vrenning@neodynamics.com\" rel=\"nofollow noopener noreferrer\">jorgen.vrenning@neodynamics.com<\/a><\/p>\n<p>This information was brought to you by Cision <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979780-1&amp;h=2495600772&amp;u=http%3A%2F%2Fnews.cision.com%2F&amp;a=http%3A%2F%2Fnews.cision.com\" rel=\"nofollow noopener noreferrer\">http:\/\/news.cision.com<\/a><\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2979780-1&amp;h=3637936372&amp;u=https%3A%2F%2Fnews.cision.com%2Fneodynamics%2Fr%2Fneodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis%2Cc3235576&amp;a=https%3A%2F%2Fnews.cision.com%2Fneodynamics%2Fr%2Fneodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis%2Cc3235576\" rel=\"nofollow noopener noreferrer\">https:\/\/news.cision.com\/neodynamics\/r\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis,c3235576<\/a>\n      <\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis-301171653.html\">http:\/\/www.prnewswire.com\/news-releases\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis-301171653.html<\/a><\/p>\n<p>SOURCE  NeoDynamics<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO89680&amp;Transmission_Id=202011120315PR_NEWS_USPR_____IO89680&amp;DateId=20201112\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire STOCKHOLM, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0NeoDynamics AB (publ), (Spotlight Stockholm: NEOD), today announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new potential indication, osteoarthritis. The William Hunter Revisited research consortium consists of six universities and academic hospitals and is collaborating with industry to identify biomarkers and test new diagnostic devices for monitoring disease progression and repair as well as developing regenerative therapies for osteoarthritis. &#8220;We look forward to collaborating with NeoDynamics and leveraging their expertise and technology to improve biopsy technique and tissue sampling in patients with osteoarthritis&#8221;, says Dr. Pieter Emans, Orthopedic Surgeon at Maastricht UMC. &#8220;The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379239","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STOCKHOLM, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0NeoDynamics AB (publ), (Spotlight Stockholm: NEOD), today announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new potential indication, osteoarthritis. The William Hunter Revisited research consortium consists of six universities and academic hospitals and is collaborating with industry to identify biomarkers and test new diagnostic devices for monitoring disease progression and repair as well as developing regenerative therapies for osteoarthritis. &#8220;We look forward to collaborating with NeoDynamics and leveraging their expertise and technology to improve biopsy technique and tissue sampling in patients with osteoarthritis&#8221;, says Dr. Pieter Emans, Orthopedic Surgeon at Maastricht UMC. &#8220;The &hellip; Continue reading &quot;NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T08:18:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis\",\"datePublished\":\"2020-11-12T08:18:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO89680&amp;sd=2020-11-12\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/\",\"name\":\"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO89680&amp;sd=2020-11-12\",\"datePublished\":\"2020-11-12T08:18:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO89680&amp;sd=2020-11-12\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO89680&amp;sd=2020-11-12\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/","og_locale":"en_US","og_type":"article","og_title":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk","og_description":"PR Newswire STOCKHOLM, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0NeoDynamics AB (publ), (Spotlight Stockholm: NEOD), today announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new potential indication, osteoarthritis. The William Hunter Revisited research consortium consists of six universities and academic hospitals and is collaborating with industry to identify biomarkers and test new diagnostic devices for monitoring disease progression and repair as well as developing regenerative therapies for osteoarthritis. &#8220;We look forward to collaborating with NeoDynamics and leveraging their expertise and technology to improve biopsy technique and tissue sampling in patients with osteoarthritis&#8221;, says Dr. Pieter Emans, Orthopedic Surgeon at Maastricht UMC. &#8220;The &hellip; Continue reading \"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T08:18:53+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis","datePublished":"2020-11-12T08:18:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/"},"wordCount":374,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/","name":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12","datePublished":"2020-11-12T08:18:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO89680&amp;sd=2020-11-12"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-enters-a-scientific-partnership-to-evaluate-its-technology-platform-in-osteoarthritis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379239"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379239\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}